PROTEOMICS 2016* Disease Proteomics
Chair: Michelle Hill
Membrane Proteomics: Surface Markers & Horizontal Signaling (#031)
5:20 PM
Quantitative proteomics of lipoproteins: insights into individual differences of lipoprotein associated proteins in the context of cardiovascular disease. (#032)
5:45 PM
A Distinct Proteomic Signature of Latently Infected Cells Reveals New Drug Targets and Immunotherapeutic Targets for HIV (#033)
6:10 PM
Data-independent mass spectrometry phenotyping of patient-derived melanoma cancer cell lines correlates with MEK inhibitor resistance independent of genotype and predicts poor patient outcome (#034)
6:30 PM